Wells Fargo Boosts Oscar Health Rating as Exchange Outlook Improves
Wells Fargo upgraded Oscar Health, citing a better 2026 outlook, improving costs, and stronger-than-expected enrollment.
/ 77 items
#XY Analyst Up/Down↓
UnitedHealth Stock Gets a Bullish Boost: BofA Sees Strong Risk/Reward Ahead
Bank of America upgraded UNH to Buy, raising target to $450 as lower healthcare costs boost earnings outlook.
Jefferies Bullish on ACHC: New Management to Drive Stability and Higher Profits
Jefferies upgraded ACHC to Buy, raised target to $30, citing better management, stability, and profit upside after strong gains.
Wall Street Upgrades Rezolute After Strong Phase 3 Trial Results in Tumor Hyperinsulinism
Rezolute’s drug showed strong Phase 3 results, reducing IV glucose needs in rare tumor HI. Analysts raised targets and turned bullish.
Bernstein Says Sell SMMT: Why Summit Therapeutics Stock Could Drop More
Bernstein remains bearish on Summit, citing doubts about trial success and expecting weak results ahead.
Cardiff Oncology Downgraded by Two Analysts After Nerviano Terminates Onvansertib License
Cardiff was downgraded by TD Cowen and H.C. Wainwright after Nerviano Medical Sciences terminated the onvansertib license agreement. Company calls termination invalid and is fighting in court.